CYTOKINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2195680, encodeId=0ff821956801a, content=伙伴们，这个杂志With Editor之后的Under Review是送出外审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Wed Mar 27 16:04:49 CST 2024, time=2024-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176798, encodeId=144221e6798dd, content=这个杂志修稿后多久能有结果？已经返修回去三个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Sun Dec 24 08:02:19 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=588424, encodeId=5bbe588424a3, content=请问老铁，投稿第二天 decision in process 是不是要被拒稿？nnsz007 2018-12-04 00:00:00 发表: 我六月在线，现在还没有期卷号…, beContent=nnsz007 2018-12-04 00:00:00 发表: 我六月在线，现在还没有期卷号…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/12/4185fc2e49302a537b9ce348adf371b7.jpg, createdBy=e88f5217484, createdName=baijing2018, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248573, encodeId=f7cd12485e312, content=审稿速度:2.0 | 投稿命中率:95.0 | 影响因子:3.9 偏重的研究方向：cytokine;inflammation;细胞因子 经验分享：投稿到接受三个月，轻松, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7df25709468, createdName=ms1000001499841876, createdTime=Tue Sep 13 01:20:15 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109841, encodeId=f65921098413c, content=请问一下大家，文章修回后一直descion in process，多久才会出结果啊呜呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Wed Jan 11 17:12:12 CST 2023, time=2023-01-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1234166, encodeId=b9ee1234166fb, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一审三周，被拒，给了修改意见，加油吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201101/048b0dabd8004d8a86109553a3149194/0d125b9b158640c4a2448bac9baced56.jpg, createdBy=f6d85425520, createdName=一鸣惊人一飞冲天, createdTime=Sat Jul 23 07:57:35 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485593, encodeId=de3e485593e4, content=7月份投了一篇，审了快4个月回来小修，现在刚修回，还不知道结果怎样，忐忑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33c950898, createdName=flyer100, createdTime=Sat Nov 26 11:54:00 CST 2011, time=2011-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488791, encodeId=9dfa488e9129, content=审稿速度超慢，八个月才给消息，小修，但问题很简单，最后还是接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 06 10:00:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087331, encodeId=4079108e331e8, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087332, encodeId=f48a108e33283, content=前两个关键词如何选择？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2024-03-27 隔壁李叔叔来自浙江省

伙伴们，这个杂志With Editor之后的Under Review是送出外审了嘛？

7 0

[GetPortalCommentsPageByObjectIdResponse(id=2195680, encodeId=0ff821956801a, content=伙伴们，这个杂志With Editor之后的Under Review是送出外审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Wed Mar 27 16:04:49 CST 2024, time=2024-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176798, encodeId=144221e6798dd, content=这个杂志修稿后多久能有结果？已经返修回去三个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Sun Dec 24 08:02:19 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=588424, encodeId=5bbe588424a3, content=请问老铁，投稿第二天 decision in process 是不是要被拒稿？nnsz007 2018-12-04 00:00:00 发表: 我六月在线，现在还没有期卷号…, beContent=nnsz007 2018-12-04 00:00:00 发表: 我六月在线，现在还没有期卷号…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/12/4185fc2e49302a537b9ce348adf371b7.jpg, createdBy=e88f5217484, createdName=baijing2018, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248573, encodeId=f7cd12485e312, content=审稿速度:2.0 | 投稿命中率:95.0 | 影响因子:3.9 偏重的研究方向：cytokine;inflammation;细胞因子 经验分享：投稿到接受三个月，轻松, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7df25709468, createdName=ms1000001499841876, createdTime=Tue Sep 13 01:20:15 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109841, encodeId=f65921098413c, content=请问一下大家，文章修回后一直descion in process，多久才会出结果啊呜呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Wed Jan 11 17:12:12 CST 2023, time=2023-01-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1234166, encodeId=b9ee1234166fb, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一审三周，被拒，给了修改意见，加油吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201101/048b0dabd8004d8a86109553a3149194/0d125b9b158640c4a2448bac9baced56.jpg, createdBy=f6d85425520, createdName=一鸣惊人一飞冲天, createdTime=Sat Jul 23 07:57:35 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485593, encodeId=de3e485593e4, content=7月份投了一篇，审了快4个月回来小修，现在刚修回，还不知道结果怎样，忐忑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33c950898, createdName=flyer100, createdTime=Sat Nov 26 11:54:00 CST 2011, time=2011-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488791, encodeId=9dfa488e9129, content=审稿速度超慢，八个月才给消息，小修，但问题很简单，最后还是接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 06 10:00:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087331, encodeId=4079108e331e8, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087332, encodeId=f48a108e33283, content=前两个关键词如何选择？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2023-12-24 1251953cm97(暂无昵称) 来自北京

这个杂志修稿后多久能有结果？已经返修回去三个月了

17 0

[GetPortalCommentsPageByObjectIdResponse(id=2195680, encodeId=0ff821956801a, content=伙伴们，这个杂志With Editor之后的Under Review是送出外审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Wed Mar 27 16:04:49 CST 2024, time=2024-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176798, encodeId=144221e6798dd, content=这个杂志修稿后多久能有结果？已经返修回去三个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Sun Dec 24 08:02:19 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=588424, encodeId=5bbe588424a3, content=请问老铁，投稿第二天 decision in process 是不是要被拒稿？nnsz007 2018-12-04 00:00:00 发表: 我六月在线，现在还没有期卷号…, beContent=nnsz007 2018-12-04 00:00:00 发表: 我六月在线，现在还没有期卷号…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/12/4185fc2e49302a537b9ce348adf371b7.jpg, createdBy=e88f5217484, createdName=baijing2018, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248573, encodeId=f7cd12485e312, content=审稿速度:2.0 | 投稿命中率:95.0 | 影响因子:3.9 偏重的研究方向：cytokine;inflammation;细胞因子 经验分享：投稿到接受三个月，轻松, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7df25709468, createdName=ms1000001499841876, createdTime=Tue Sep 13 01:20:15 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109841, encodeId=f65921098413c, content=请问一下大家，文章修回后一直descion in process，多久才会出结果啊呜呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Wed Jan 11 17:12:12 CST 2023, time=2023-01-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1234166, encodeId=b9ee1234166fb, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一审三周，被拒，给了修改意见，加油吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201101/048b0dabd8004d8a86109553a3149194/0d125b9b158640c4a2448bac9baced56.jpg, createdBy=f6d85425520, createdName=一鸣惊人一飞冲天, createdTime=Sat Jul 23 07:57:35 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485593, encodeId=de3e485593e4, content=7月份投了一篇，审了快4个月回来小修，现在刚修回，还不知道结果怎样，忐忑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33c950898, createdName=flyer100, createdTime=Sat Nov 26 11:54:00 CST 2011, time=2011-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488791, encodeId=9dfa488e9129, content=审稿速度超慢，八个月才给消息，小修，但问题很简单，最后还是接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 06 10:00:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087331, encodeId=4079108e331e8, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087332, encodeId=f48a108e33283, content=前两个关键词如何选择？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2020-04-08 baijing2018

请问老铁，投稿第二天 decision in process 是不是要被拒稿？nnsz007 2018-12-04 00:00:00 发表:
我六月在线，现在还没有期卷号…

nnsz007 2018-12-04 00:00:00 发表: 我六月在线，现在还没有期卷号…

141 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2195680, encodeId=0ff821956801a, content=伙伴们，这个杂志With Editor之后的Under Review是送出外审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Wed Mar 27 16:04:49 CST 2024, time=2024-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176798, encodeId=144221e6798dd, content=这个杂志修稿后多久能有结果？已经返修回去三个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Sun Dec 24 08:02:19 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=588424, encodeId=5bbe588424a3, content=请问老铁，投稿第二天 decision in process 是不是要被拒稿？nnsz007 2018-12-04 00:00:00 发表: 我六月在线，现在还没有期卷号…, beContent=nnsz007 2018-12-04 00:00:00 发表: 我六月在线，现在还没有期卷号…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/12/4185fc2e49302a537b9ce348adf371b7.jpg, createdBy=e88f5217484, createdName=baijing2018, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248573, encodeId=f7cd12485e312, content=审稿速度:2.0 | 投稿命中率:95.0 | 影响因子:3.9 偏重的研究方向：cytokine;inflammation;细胞因子 经验分享：投稿到接受三个月，轻松, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7df25709468, createdName=ms1000001499841876, createdTime=Tue Sep 13 01:20:15 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109841, encodeId=f65921098413c, content=请问一下大家，文章修回后一直descion in process，多久才会出结果啊呜呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Wed Jan 11 17:12:12 CST 2023, time=2023-01-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1234166, encodeId=b9ee1234166fb, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一审三周，被拒，给了修改意见，加油吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201101/048b0dabd8004d8a86109553a3149194/0d125b9b158640c4a2448bac9baced56.jpg, createdBy=f6d85425520, createdName=一鸣惊人一飞冲天, createdTime=Sat Jul 23 07:57:35 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485593, encodeId=de3e485593e4, content=7月份投了一篇，审了快4个月回来小修，现在刚修回，还不知道结果怎样，忐忑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33c950898, createdName=flyer100, createdTime=Sat Nov 26 11:54:00 CST 2011, time=2011-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488791, encodeId=9dfa488e9129, content=审稿速度超慢，八个月才给消息，小修，但问题很简单，最后还是接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 06 10:00:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087331, encodeId=4079108e331e8, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087332, encodeId=f48a108e33283, content=前两个关键词如何选择？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2022-09-13 ms1000001499841876

审稿速度:2.0 | 投稿命中率:95.0 | 影响因子:3.9
偏重的研究方向：cytokine;inflammation;细胞因子
经验分享：投稿到接受三个月，轻松

58 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2195680, encodeId=0ff821956801a, content=伙伴们，这个杂志With Editor之后的Under Review是送出外审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Wed Mar 27 16:04:49 CST 2024, time=2024-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176798, encodeId=144221e6798dd, content=这个杂志修稿后多久能有结果？已经返修回去三个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Sun Dec 24 08:02:19 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=588424, encodeId=5bbe588424a3, content=请问老铁，投稿第二天 decision in process 是不是要被拒稿？nnsz007 2018-12-04 00:00:00 发表: 我六月在线，现在还没有期卷号…, beContent=nnsz007 2018-12-04 00:00:00 发表: 我六月在线，现在还没有期卷号…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/12/4185fc2e49302a537b9ce348adf371b7.jpg, createdBy=e88f5217484, createdName=baijing2018, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248573, encodeId=f7cd12485e312, content=审稿速度:2.0 | 投稿命中率:95.0 | 影响因子:3.9 偏重的研究方向：cytokine;inflammation;细胞因子 经验分享：投稿到接受三个月，轻松, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7df25709468, createdName=ms1000001499841876, createdTime=Tue Sep 13 01:20:15 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109841, encodeId=f65921098413c, content=请问一下大家，文章修回后一直descion in process，多久才会出结果啊呜呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Wed Jan 11 17:12:12 CST 2023, time=2023-01-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1234166, encodeId=b9ee1234166fb, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一审三周，被拒，给了修改意见，加油吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201101/048b0dabd8004d8a86109553a3149194/0d125b9b158640c4a2448bac9baced56.jpg, createdBy=f6d85425520, createdName=一鸣惊人一飞冲天, createdTime=Sat Jul 23 07:57:35 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485593, encodeId=de3e485593e4, content=7月份投了一篇，审了快4个月回来小修，现在刚修回，还不知道结果怎样，忐忑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33c950898, createdName=flyer100, createdTime=Sat Nov 26 11:54:00 CST 2011, time=2011-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488791, encodeId=9dfa488e9129, content=审稿速度超慢，八个月才给消息，小修，但问题很简单，最后还是接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 06 10:00:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087331, encodeId=4079108e331e8, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087332, encodeId=f48a108e33283, content=前两个关键词如何选择？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2023-01-11 ms7000001099295732 来自四川省

请问一下大家，文章修回后一直descion in process，多久才会出结果啊呜呜呜呜

45 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2195680, encodeId=0ff821956801a, content=伙伴们，这个杂志With Editor之后的Under Review是送出外审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Wed Mar 27 16:04:49 CST 2024, time=2024-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176798, encodeId=144221e6798dd, content=这个杂志修稿后多久能有结果？已经返修回去三个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Sun Dec 24 08:02:19 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=588424, encodeId=5bbe588424a3, content=请问老铁，投稿第二天 decision in process 是不是要被拒稿？nnsz007 2018-12-04 00:00:00 发表: 我六月在线，现在还没有期卷号…, beContent=nnsz007 2018-12-04 00:00:00 发表: 我六月在线，现在还没有期卷号…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/12/4185fc2e49302a537b9ce348adf371b7.jpg, createdBy=e88f5217484, createdName=baijing2018, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248573, encodeId=f7cd12485e312, content=审稿速度:2.0 | 投稿命中率:95.0 | 影响因子:3.9 偏重的研究方向：cytokine;inflammation;细胞因子 经验分享：投稿到接受三个月，轻松, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7df25709468, createdName=ms1000001499841876, createdTime=Tue Sep 13 01:20:15 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109841, encodeId=f65921098413c, content=请问一下大家，文章修回后一直descion in process，多久才会出结果啊呜呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Wed Jan 11 17:12:12 CST 2023, time=2023-01-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1234166, encodeId=b9ee1234166fb, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一审三周，被拒，给了修改意见，加油吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201101/048b0dabd8004d8a86109553a3149194/0d125b9b158640c4a2448bac9baced56.jpg, createdBy=f6d85425520, createdName=一鸣惊人一飞冲天, createdTime=Sat Jul 23 07:57:35 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485593, encodeId=de3e485593e4, content=7月份投了一篇，审了快4个月回来小修，现在刚修回，还不知道结果怎样，忐忑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33c950898, createdName=flyer100, createdTime=Sat Nov 26 11:54:00 CST 2011, time=2011-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488791, encodeId=9dfa488e9129, content=审稿速度超慢，八个月才给消息，小修，但问题很简单，最后还是接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 06 10:00:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087331, encodeId=4079108e331e8, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087332, encodeId=f48a108e33283, content=前两个关键词如何选择？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2022-07-23 一鸣惊人一飞冲天

审稿速度:1.0 | 投稿命中率:50.0
经验分享：一审三周，被拒，给了修改意见，加油吧！

50 0

[GetPortalCommentsPageByObjectIdResponse(id=2195680, encodeId=0ff821956801a, content=伙伴们，这个杂志With Editor之后的Under Review是送出外审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Wed Mar 27 16:04:49 CST 2024, time=2024-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176798, encodeId=144221e6798dd, content=这个杂志修稿后多久能有结果？已经返修回去三个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Sun Dec 24 08:02:19 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=588424, encodeId=5bbe588424a3, content=请问老铁，投稿第二天 decision in process 是不是要被拒稿？nnsz007 2018-12-04 00:00:00 发表: 我六月在线，现在还没有期卷号…, beContent=nnsz007 2018-12-04 00:00:00 发表: 我六月在线，现在还没有期卷号…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/12/4185fc2e49302a537b9ce348adf371b7.jpg, createdBy=e88f5217484, createdName=baijing2018, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248573, encodeId=f7cd12485e312, content=审稿速度:2.0 | 投稿命中率:95.0 | 影响因子:3.9 偏重的研究方向：cytokine;inflammation;细胞因子 经验分享：投稿到接受三个月，轻松, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7df25709468, createdName=ms1000001499841876, createdTime=Tue Sep 13 01:20:15 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109841, encodeId=f65921098413c, content=请问一下大家，文章修回后一直descion in process，多久才会出结果啊呜呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Wed Jan 11 17:12:12 CST 2023, time=2023-01-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1234166, encodeId=b9ee1234166fb, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一审三周，被拒，给了修改意见，加油吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201101/048b0dabd8004d8a86109553a3149194/0d125b9b158640c4a2448bac9baced56.jpg, createdBy=f6d85425520, createdName=一鸣惊人一飞冲天, createdTime=Sat Jul 23 07:57:35 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485593, encodeId=de3e485593e4, content=7月份投了一篇，审了快4个月回来小修，现在刚修回，还不知道结果怎样，忐忑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33c950898, createdName=flyer100, createdTime=Sat Nov 26 11:54:00 CST 2011, time=2011-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488791, encodeId=9dfa488e9129, content=审稿速度超慢，八个月才给消息，小修，但问题很简单，最后还是接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 06 10:00:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087331, encodeId=4079108e331e8, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087332, encodeId=f48a108e33283, content=前两个关键词如何选择？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2011-11-26 flyer100

7月份投了一篇，审了快4个月回来小修，现在刚修回，还不知道结果怎样，忐忑啊

395 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2195680, encodeId=0ff821956801a, content=伙伴们，这个杂志With Editor之后的Under Review是送出外审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Wed Mar 27 16:04:49 CST 2024, time=2024-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176798, encodeId=144221e6798dd, content=这个杂志修稿后多久能有结果？已经返修回去三个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Sun Dec 24 08:02:19 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=588424, encodeId=5bbe588424a3, content=请问老铁，投稿第二天 decision in process 是不是要被拒稿？nnsz007 2018-12-04 00:00:00 发表: 我六月在线，现在还没有期卷号…, beContent=nnsz007 2018-12-04 00:00:00 发表: 我六月在线，现在还没有期卷号…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/12/4185fc2e49302a537b9ce348adf371b7.jpg, createdBy=e88f5217484, createdName=baijing2018, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248573, encodeId=f7cd12485e312, content=审稿速度:2.0 | 投稿命中率:95.0 | 影响因子:3.9 偏重的研究方向：cytokine;inflammation;细胞因子 经验分享：投稿到接受三个月，轻松, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7df25709468, createdName=ms1000001499841876, createdTime=Tue Sep 13 01:20:15 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109841, encodeId=f65921098413c, content=请问一下大家，文章修回后一直descion in process，多久才会出结果啊呜呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Wed Jan 11 17:12:12 CST 2023, time=2023-01-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1234166, encodeId=b9ee1234166fb, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一审三周，被拒，给了修改意见，加油吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201101/048b0dabd8004d8a86109553a3149194/0d125b9b158640c4a2448bac9baced56.jpg, createdBy=f6d85425520, createdName=一鸣惊人一飞冲天, createdTime=Sat Jul 23 07:57:35 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485593, encodeId=de3e485593e4, content=7月份投了一篇，审了快4个月回来小修，现在刚修回，还不知道结果怎样，忐忑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33c950898, createdName=flyer100, createdTime=Sat Nov 26 11:54:00 CST 2011, time=2011-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488791, encodeId=9dfa488e9129, content=审稿速度超慢，八个月才给消息，小修，但问题很简单，最后还是接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 06 10:00:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087331, encodeId=4079108e331e8, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087332, encodeId=f48a108e33283, content=前两个关键词如何选择？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2012-06-06 匿名用户

审稿速度超慢，八个月才给消息，小修，但问题很简单，最后还是接收了

391 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2195680, encodeId=0ff821956801a, content=伙伴们，这个杂志With Editor之后的Under Review是送出外审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Wed Mar 27 16:04:49 CST 2024, time=2024-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176798, encodeId=144221e6798dd, content=这个杂志修稿后多久能有结果？已经返修回去三个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Sun Dec 24 08:02:19 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=588424, encodeId=5bbe588424a3, content=请问老铁，投稿第二天 decision in process 是不是要被拒稿？nnsz007 2018-12-04 00:00:00 发表: 我六月在线，现在还没有期卷号…, beContent=nnsz007 2018-12-04 00:00:00 发表: 我六月在线，现在还没有期卷号…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/12/4185fc2e49302a537b9ce348adf371b7.jpg, createdBy=e88f5217484, createdName=baijing2018, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248573, encodeId=f7cd12485e312, content=审稿速度:2.0 | 投稿命中率:95.0 | 影响因子:3.9 偏重的研究方向：cytokine;inflammation;细胞因子 经验分享：投稿到接受三个月，轻松, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7df25709468, createdName=ms1000001499841876, createdTime=Tue Sep 13 01:20:15 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109841, encodeId=f65921098413c, content=请问一下大家，文章修回后一直descion in process，多久才会出结果啊呜呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Wed Jan 11 17:12:12 CST 2023, time=2023-01-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1234166, encodeId=b9ee1234166fb, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一审三周，被拒，给了修改意见，加油吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201101/048b0dabd8004d8a86109553a3149194/0d125b9b158640c4a2448bac9baced56.jpg, createdBy=f6d85425520, createdName=一鸣惊人一飞冲天, createdTime=Sat Jul 23 07:57:35 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485593, encodeId=de3e485593e4, content=7月份投了一篇，审了快4个月回来小修，现在刚修回，还不知道结果怎样，忐忑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33c950898, createdName=flyer100, createdTime=Sat Nov 26 11:54:00 CST 2011, time=2011-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488791, encodeId=9dfa488e9129, content=审稿速度超慢，八个月才给消息，小修，但问题很简单，最后还是接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 06 10:00:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087331, encodeId=4079108e331e8, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087332, encodeId=f48a108e33283, content=前两个关键词如何选择？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2021-12-29 小动量

投稿中一定要有Graphicalabstract么？

59 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2195680, encodeId=0ff821956801a, content=伙伴们，这个杂志With Editor之后的Under Review是送出外审了嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210929/9d45d09216384c0abbf68ca1abb9886d/74b3e233c72b43b3910e9989453ba9a7.png, createdBy=4db65493123, createdName=隔壁李叔叔, createdTime=Wed Mar 27 16:04:49 CST 2024, time=2024-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2176798, encodeId=144221e6798dd, content=这个杂志修稿后多久能有结果？已经返修回去三个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Sun Dec 24 08:02:19 CST 2023, time=2023-12-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=588424, encodeId=5bbe588424a3, content=请问老铁，投稿第二天 decision in process 是不是要被拒稿？nnsz007 2018-12-04 00:00:00 发表: 我六月在线，现在还没有期卷号…, beContent=nnsz007 2018-12-04 00:00:00 发表: 我六月在线，现在还没有期卷号…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/12/4185fc2e49302a537b9ce348adf371b7.jpg, createdBy=e88f5217484, createdName=baijing2018, createdTime=Wed Apr 08 00:00:00 CST 2020, time=2020-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248573, encodeId=f7cd12485e312, content=审稿速度:2.0 | 投稿命中率:95.0 | 影响因子:3.9 偏重的研究方向：cytokine;inflammation;细胞因子 经验分享：投稿到接受三个月，轻松, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7df25709468, createdName=ms1000001499841876, createdTime=Tue Sep 13 01:20:15 CST 2022, time=2022-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109841, encodeId=f65921098413c, content=请问一下大家，文章修回后一直descion in process，多久才会出结果啊呜呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=67d25607485, createdName=ms7000001099295732, createdTime=Wed Jan 11 17:12:12 CST 2023, time=2023-01-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1234166, encodeId=b9ee1234166fb, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：一审三周，被拒，给了修改意见，加油吧！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201101/048b0dabd8004d8a86109553a3149194/0d125b9b158640c4a2448bac9baced56.jpg, createdBy=f6d85425520, createdName=一鸣惊人一飞冲天, createdTime=Sat Jul 23 07:57:35 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485593, encodeId=de3e485593e4, content=7月份投了一篇，审了快4个月回来小修，现在刚修回，还不知道结果怎样，忐忑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33c950898, createdName=flyer100, createdTime=Sat Nov 26 11:54:00 CST 2011, time=2011-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488791, encodeId=9dfa488e9129, content=审稿速度超慢，八个月才给消息，小修，但问题很简单，最后还是接收了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jun 06 10:00:00 CST 2012, time=2012-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087331, encodeId=4079108e331e8, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087332, encodeId=f48a108e33283, content=前两个关键词如何选择？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2021-12-28 小动量

前两个关键词如何选择？

78 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务